acetylcysteine has been researched along with Ureteral Obstruction in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Honma, S; Sakai, M; Soma, I; Tani, I; Toriyabe, K; Yoshida, M | 1 |
Aydın, A; Börcek, P; Karakan, T; Koca, G; Öğüş, E; Sunay, M | 1 |
Gan, XX; Lu, LM; Miao, NJ; Shen, Y; Xu, D; Xu, JL; Xue, H; Zhang, W; Zhou, L | 1 |
Hamatani, H; Hiromura, K; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakairi, T; Takahashi, S; Takeuchi, S; Tomioka, M | 1 |
Andrade, L; Danilovic, A; Libório, AB; Sanches, TR; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
Benderev, TV | 1 |
Caponegro, PJ; Leadbetter, GW | 1 |
7 other study(ies) available for acetylcysteine and Ureteral Obstruction
Article | Year |
---|---|
Effect of N-Acetyl Cysteine on Renal Interstitial Fibrosis in Mice.
Topics: Acetylcysteine; Animals; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Reactive Oxygen Species; Ureteral Obstruction | 2020 |
Do Montelukast Sodium and N-Acetylcysteine Have a Nephroprotective Effect on Unilateral Ureteral Obstruction? A Placebo Controlled Trial in a Rat Model.
Topics: Acetates; Acetylcysteine; Animals; Cyclopropanes; Disease Models, Animal; Kidney Diseases; Male; Placebos; Quinolines; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Sulfides; Ureteral Obstruction | 2015 |
N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cell Line; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Ureteral Obstruction | 2016 |
Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Topics: Acetylcysteine; Actins; Animals; Cells, Cultured; Cysteine Proteinase Inhibitors; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Kidney Diseases; Leupeptins; Male; Nerve Tissue Proteins; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Smad Proteins, Receptor-Regulated; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta; Ureteral Obstruction | 2011 |
N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
Topics: Acetylcysteine; Animals; Aquaporin 2; Glomerular Filtration Rate; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Osmolar Concentration; Rats; Rats, Wistar; Renal Circulation; Thiobarbituric Acid Reactive Substances; Ureteral Obstruction; Urine | 2008 |
Acetylcysteine for urinary tract mucolysis.
Topics: Acetylcysteine; Adult; Humans; Ileum; Male; Mucus; Postoperative Complications; Recurrence; Ureter; Ureteral Obstruction | 1988 |
Acute ureteral obstruction secondary to mucoid impaction in supravesical diversion. Treatment with N-acetylcysteine.
Topics: Acetylcysteine; Adult; Colon, Sigmoid; Female; Humans; Hydronephrosis; Ileum; Male; Mucus; Postoperative Complications; Proteins; Radiography; Ureter; Ureteral Obstruction; Urinary Diversion | 1974 |